ASTERIAS BIOTHERAPEUTICS, INC. filed this 8-K on 20171016

Document Outline
Entire Document (529.8 KB)
Subdocument - 8-K - 8-K
  Page 1 - N/A
  Page 2 - N/A
  Page 3 - /s/ Ryan D. Chavez
Subdocument - EX-5.1 - EXHIBIT 5.1
  Page 1 - Sale of securities registered pursuant to Registration Statement on Form S-3 (File No. 333-215154)
  Page 2 - N/A
Subdocument - EX-10.1 - EXHIBIT 10.1
  Page 1 - Agreement
  Page 2 - Commission
  Page 3 - Intellectual Property Rights
  Page 4 - Rule 424
  Page 5 - Closing
  Page 6 - N/A
  Page 7 - Representations and Warranties of the Company
  Page 8 - No Conflicts
  Page 9 - Issuance of the Securities; Registration
  Page 10 - SEC Reports; Financial Statements
  Page 11 - Litigation
  Page 12 - Environmental Laws
  Page 13 - Intellectual Property
  Page 14 - Sarbanes-Oxley; Internal Accounting Controls
  Page 15 - Listing and Maintenance Requirements
  Page 16 - Solvency
  Page 17 - Foreign Corrupt Practices
  Page 18 - Regulation M Compliance
  Page 19 - Representations and Warranties of the Purchasers
  Page 20 - Access to Information
  Page 21 - Furnishing of Information
  Page 22 - Shareholder Rights Plan
  Page 23 - Indemnification of Purchasers
  Page 24 - N/A
  Page 25 - Equal Treatment of Purchasers
  Page 26 - Fees and Expenses
  Page 27 - Headings
  Page 28 - Execution
  Page 29 - Independent Nature of Purchasers Obligations and Rights
  Page 30 - N/A
  Page 31 - N/A
Subdocument - EX-10.2 - EXHIBIT 10.2
  Page 1 - STRICTLY CONFIDENTIAL
  Page 2 - Expenses
  Page 3 - Limitation of Engagement to the Company
  Page 4 - Limitation of Chardan s Liability to the Company
  Page 5 - N/A
Subdocument - EX-99.1 - EXHIBIT 99.1
  Page 1 - N/A
  Page 2 - InvestorRelations@asteriasbio.com